On 2024-03-19, ImmunityBio, Inc. (IBRX) announced earnings per share of $-0.19 for the fiscal quarter ending 2023-12-31, missing the average analyst estimate of $-0.18.
The next expected annoucement date for quarterly earnings is 2024-05-09, with an average estimated earnings per share of $-0.16 for the fiscal quarter ending 2024-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-03-19 | 2023-12-31 | $-0.18 | $-0.19 |
| 2023-11-08 | 2023-09-30 | $-0.27 | $-0.19 |
| 2023-08-08 | 2023-06-30 | $-0.26 | $-0.28 |
| 2023-05-11 | 2023-03-31 | $-0.27 | $-0.27 |
| 2022-11-08 | 2022-09-30 | $-0.23 | $-0.28 |
| 2022-05-10 | 2022-03-31 | $-0.22 | $-0.26 |
| 2021-08-12 | 2021-06-30 | $-0.12 | $-0.23 |
| 2020-08-07 | 2020-06-30 | $-0.19 | $-0.20 |
| 2020-05-11 | 2020-03-31 | $-0.17 | $-0.19 |
| 2020-03-25 | 2019-12-31 | $-0.20 | $-0.16 |
| 2019-11-05 | 2019-09-30 | -- | $-0.16 |
| 2019-08-06 | 2019-06-30 | $-0.25 | $-0.17 |
| 2019-05-08 | 2019-03-31 | $-0.23 | $-0.22 |
| 2019-03-13 | 2018-12-31 | -- | $-0.22 |
| 2018-11-07 | 2018-09-30 | $-0.37 | $-0.30 |
| 2018-05-07 | 2018-03-31 | $-0.34 | $-0.35 |
| 2018-03-12 | 2017-12-31 | -- | $-0.31 |
| 2017-11-07 | 2017-09-30 | -- | $-0.30 |
| 2017-08-07 | 2017-06-30 | $-0.32 | $-0.29 |
| 2017-05-08 | 2017-03-31 | $-0.39 | $-0.30 |
| 2017-03-15 | 2016-12-31 | -- | $-0.29 |
| 2016-11-10 | 2016-09-30 | -- | $-0.39 |
| 2016-08-15 | 2016-06-30 | $-0.35 | $-0.41 |
| 2016-05-16 | 2016-03-31 | $-0.24 | $-0.38 |
| 2016-03-30 | 2015-12-31 | -- | $-0.97 |
| 2015-11-12 | 2015-09-30 | $-0.07 | $-0.55 |
| 2015-09-10 | 2015-06-30 | -- | $-1.29 |